600056 中国医药
已收盘 03-30 15:00:00
资讯
新帖
简况
中国医药:子公司注射用头孢噻肟钠等产品拟中标第八批全国药品集采
E公司 · 03-29 23:11
中国医药:子公司注射用头孢噻肟钠等产品拟中标第八批全国药品集采
艾迪药业(688488.SH)与中国医药保健品有限公司签订《合作框架协议》
智通财经 · 03-21
艾迪药业(688488.SH)与中国医药保健品有限公司签订《合作框架协议》
中国医药产业的“可计算”革命
锦缎 · 03-20
中国医药产业的“可计算”革命
雅本化学:公司与中国医药无供货关系
每日经济新闻 · 03-16
雅本化学:公司与中国医药无供货关系
双重利好!中医药板块应声走强 中国医药一度涨超6%
财联社 · 03-16
双重利好!中医药板块应声走强 中国医药一度涨超6%
研发投入856万元 中国医药注射用特利加压素获批
新京报 · 03-08
研发投入856万元 中国医药注射用特利加压素获批
中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件
智通财经 · 03-07
中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件
中国医药:子公司注射用特利加压素获得药品注册批件
财通社 · 03-07
中国医药:子公司注射用特利加压素获得药品注册批件
中国医药3月6日遭北向资金减持200.07万股
自选股智能写手 · 03-07
中国医药3月6日遭北向资金减持200.07万股
中国医药(600056.SH):“注射用哌拉西林钠他唑巴坦钠”通过仿制药一致性评价
智通财经 · 03-03
中国医药(600056.SH):“注射用哌拉西林钠他唑巴坦钠”通过仿制药一致性评价
中国医药:为控股公司恒德医药办理商业汇票承兑提供担保,本次担保最高额金额为2000万元
每经网 · 03-01
中国医药:为控股公司恒德医药办理商业汇票承兑提供担保,本次担保最高额金额为2000万元
中国医药(600056.SH)子公司盐酸伐昔洛韦片通过仿制药一致性评价
智通财经 · 02-21
中国医药(600056.SH)子公司盐酸伐昔洛韦片通过仿制药一致性评价
中国医药:子公司盐酸伐昔洛韦片通过仿制药一致性评价
财联社 · 02-21
中国医药:子公司盐酸伐昔洛韦片通过仿制药一致性评价
中国医药2月20日遭北向资金减持411.68万股
自选股智能写手 · 02-21
中国医药2月20日遭北向资金减持411.68万股
医药商业板块开盘下挫
和讯 · 02-20
医药商业板块开盘下挫
医药股午后持续走强
和讯 · 02-17
医药股午后持续走强
公司有自己的中药种植基地吗? 中国医药回应
每日经济新闻 · 02-17
公司有自己的中药种植基地吗? 中国医药回应
中国医药2月15日获融资净买入2066万元 环比增加341.38%
自选股智能写手 · 02-16
中国医药2月15日获融资净买入2066万元 环比增加341.38%
中国医药2月15日遭北向资金减持332.52万股
自选股智能写手 · 02-16
中国医药2月15日遭北向资金减持332.52万股
中国医药2月13日获北向资金加仓277.23万股
自选股智能写手 · 02-14
中国医药2月13日获北向资金加仓277.23万股
加载更多
公司概况
公司名称:
中国医药健康产业股份有限公司
所属行业:
批发业
上市日期:
1997-05-15
主营业务:
中国医药健康产业股份有限公司建立了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的贸、工、技、服一体化产业格局,全面推动工商贸三大业务板块业务整合,积极发挥协同优势。主要产品有原料药、制剂药、中成药、医药商业、国际贸易。从最新公布的权威行业排名显示,公司位列2020年度中国医药工业百强榜化药企业排名第35位;中国医药-重庆医药联合体位列2020年医药流通百强第5位。
发行价格:
7.02
{"stockData":{"symbol":"600056","market":"SH","secType":"STK","nameCN":"中国医药","latestPrice":13.61,"timestamp":1680159600000,"preClose":13.75,"halted":0,"volume":24122321,"delay":0,"floatShares":1495000000,"shares":1496000000,"eps":0.3866,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.14,"latestTime":"03-30 15:00:00","open":13.71,"high":13.75,"low":13.43,"amount":326000000,"amplitude":0.0233,"askPrice":13.62,"askSize":295,"bidPrice":13.61,"bidSize":1907,"shortable":0,"etf":0,"ttmEps":0.3866,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1680226200000},"adr":0,"adjPreClose":13.75,"symbolType":"stock","highLimit":15.13,"lowLimit":12.38,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1495879748,"pbRate":1.88,"roa":"--","roe":"7.08%","epsLYR":0.6056,"committee":0.26965,"marketValue":20359000000,"floatMarketCap":20352000000,"peRate":35.204347,"changeRate":-0.0102,"turnoverRate":0.0161,"status":1},"requestUrl":"/m/hq/s/600056","defaultTab":"news","newsList":[{"id":"2323200887","title":"中国医药:子公司注射用头孢噻肟钠等产品拟中标第八批全国药品集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2323200887","media":"E公司","top":-1,"share":"https://www.laohu8.com/m/news/2323200887?lang=zh_CN&edition=full","pubTime":"2023-03-29 23:11","pubTimestamp":1680102660,"startTime":"0","endTime":"0","summary":"e公司讯,中国医药(600056)3月29日晚间公告,公司下属子公司三洋药业通过仿制药质量和疗效一致性评价的产品注射用哌拉西林钠他唑巴坦钠、注射用头孢噻肟钠、醋酸阿托西班注射液拟中标第八批全国药品集中采购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032923115783579812&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032923115783579812&s=b","is_publish_highlight":false},{"id":"2321641170","title":"艾迪药业(688488.SH)与中国医药保健品有限公司签订《合作框架协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2321641170","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2321641170?lang=zh_CN&edition=full","pubTime":"2023-03-21 18:18","pubTimestamp":1679393902,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾迪药业 发布公告,公司与中国医药保健品有限公司经友好协商,达成合作意向并于近日签订了《合作框架协议》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/895728.html","is_publish_highlight":false},{"id":"2320522209","title":"中国医药产业的“可计算”革命","url":"https://stock-news.laohu8.com/highlight/detail?id=2320522209","media":"锦缎","top":-1,"share":"https://www.laohu8.com/m/news/2320522209?lang=zh_CN&edition=full","pubTime":"2023-03-20 07:59","pubTimestamp":1679270351,"startTime":"0","endTime":"0","summary":"比如本文将深入透视的发生在我国医疗、医药产业的这场深入变革,一定程度上,正是“可计算”逻辑的表彰——它就是:DRG。作为中国医药产业支付的兜底者,医保局实则是中国医药市场的最大客户。经过分析,我们认为这股无形的力量将会推动中国医药产业出现5个趋势性的变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://tech.ifeng.com/c/8OIfTXaC988","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8OIfTXaC988","is_publish_highlight":false},{"id":"2319335242","title":"雅本化学:公司与中国医药无供货关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2319335242","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2319335242?lang=zh_CN&edition=full","pubTime":"2023-03-16 16:47","pubTimestamp":1678956449,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:贵司与中国医药有供货关系吗?雅本化学(300261.SZ)3月16日在投资者互动平台表示,公司与中国医药无供货关系。(记者 姚祥云)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164815826bc277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164815826bc277&s=b","is_publish_highlight":false},{"id":"2319831773","title":"双重利好!中医药板块应声走强 中国医药一度涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319831773","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2319831773?lang=zh_CN&edition=full","pubTime":"2023-03-16 13:07","pubTimestamp":1678943234,"startTime":"0","endTime":"0","summary":"财联社3月16日讯 受益中医药利好政策及药材价格上涨,港股中医药板块一度走强,其中中国医药盘中最高涨幅超6%,但随后涨幅收窄。截至发稿,中国医药、神威药业、白云山分别上涨4.21%、2.33%、1.62%。同时近期各类中药材价格出现大范围、大幅度上涨,部分药材价格涨幅惊人。一同涌入的,还有看好中药市场的各路资金,进一步助推中药材价格。此举有望进一步推动中药传承创新发展,激发中药新药研制的活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316130737826b9fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316130737826b9fd1&s=b","is_publish_highlight":false},{"id":"2317408756","title":"研发投入856万元 中国医药注射用特利加压素获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2317408756","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2317408756?lang=zh_CN&edition=full","pubTime":"2023-03-08 17:18","pubTimestamp":1678267119,"startTime":"0","endTime":"0","summary":"pan>收到《药品注册证书》,获批上市。pan>pan>适用于胃肠道、泌尿生殖系统、术后出血的治疗以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性(对儿茶酚胺抵抗性)休克等治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081720238267e182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081720238267e182&s=b","is_publish_highlight":false},{"id":"2317546873","title":"中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2317546873","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2317546873?lang=zh_CN&edition=full","pubTime":"2023-03-07 17:43","pubTimestamp":1678182195,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国医药 发布公告,近日,公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。根据米内网数据库国内市场样本医院用药销售统计显示,2021年注射用特利加压素样本医院销售额约为2.34亿元,2022年上半年销售额约为1.29亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/887968.html","is_publish_highlight":false},{"id":"2317463439","title":"中国医药:子公司注射用特利加压素获得药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2317463439","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2317463439?lang=zh_CN&edition=full","pubTime":"2023-03-07 17:42","pubTimestamp":1678182120,"startTime":"0","endTime":"0","summary":"【中国医药:子公司注射用特利加压素获得药品注册批件】中国医药公告,子公司注射用特利加压素获得药品注册批件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030717425982674325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030717425982674325&s=b","is_publish_highlight":false},{"id":"2317487713","title":"中国医药3月6日遭北向资金减持200.07万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2317487713","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2317487713?lang=zh_CN&edition=full","pubTime":"2023-03-07 09:30","pubTimestamp":1678152627,"startTime":"0","endTime":"0","summary":"3月6日,北向资金减持中国医药200.07万股。截止当日收盘,沪股通共持有中国医药1800.84万股,占流通股1.20%。沪股通减持金额前五个股分别为招商银行、工业富联、中国联通、亨通光电、兴业银行。中国医药近5个交易日上涨2.39%,沪股通累计增持8.33万股;近20个交易日上涨4.97%,沪股通累计减持56.65万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030709304482ba0b64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030709304482ba0b64&s=b","is_publish_highlight":false},{"id":"2316944572","title":"中国医药(600056.SH):“注射用哌拉西林钠他唑巴坦钠”通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2316944572","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2316944572?lang=zh_CN&edition=full","pubTime":"2023-03-03 15:56","pubTimestamp":1677830181,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国医药(600056.SH)发布公告,近日,公司下属全资子公司海南通用三洋药业有限公司(以下简称“通用三洋”)收到国家药品监督管理局(以下简称“国家药监局”)核准签发的四份注射用哌拉西林钠他唑巴坦钠(以下简称“该药品”)《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/886599.html","is_publish_highlight":false},{"id":"2316069051","title":"中国医药:为控股公司恒德医药办理商业汇票承兑提供担保,本次担保最高额金额为2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2316069051","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2316069051?lang=zh_CN&edition=full","pubTime":"2023-03-01 18:29","pubTimestamp":1677666572,"startTime":"0","endTime":"0","summary":"中国医药 3月1日晚间发布公告称,根据统筹考虑授信资源的安排,结合控股公司实际业务需要,公司与中国 农业银行 股份有限公司石河子市兵团支行签订《最高额保证合同》,为控股公司恒德医药办理商业汇票承兑提供担保,本次担保最高额金额为2,000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030118410784149b48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030118410784149b48&s=b","is_publish_highlight":false},{"id":"2313770007","title":"中国医药(600056.SH)子公司盐酸伐昔洛韦片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2313770007","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2313770007?lang=zh_CN&edition=full","pubTime":"2023-02-21 16:28","pubTimestamp":1676968120,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国医药(600056.SH)发布公告,近日,公司下属子公司科益药业收到国家药监局核准签发的一份盐酸伐昔洛韦片《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。盐酸伐昔洛韦片为抗病毒药,主要用于治疗带状疱疹,治疗单纯疱疹病毒感染,预防(抑制)单纯疱疹病毒感染的复发。截至公告披露日,科益药业该药品一致性评价研发投入约为900万元(未经审计)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/879757.html","is_publish_highlight":false},{"id":"2313749770","title":"中国医药:子公司盐酸伐昔洛韦片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2313749770","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2313749770?lang=zh_CN&edition=full","pubTime":"2023-02-21 16:25","pubTimestamp":1676967943,"startTime":"0","endTime":"0","summary":"【中国医药:子公司盐酸伐昔洛韦片通过仿制药一致性评价】财联社2月21日电,中国医药公告,公司下属子公司科益药业收到国家药监局核准签发的一份盐酸伐昔洛韦片《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cailian_livestock","url":"https://www.cls.cn/detail/1273301","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.cls.cn/detail/1273301","is_publish_highlight":false},{"id":"2313723665","title":"中国医药2月20日遭北向资金减持411.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2313723665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2313723665?lang=zh_CN&edition=full","pubTime":"2023-02-21 09:30","pubTimestamp":1676943007,"startTime":"0","endTime":"0","summary":"2月20日,北向资金减持中国医药411.68万股。截止当日收盘,沪股通共持有中国医药1678.13万股,占流通股1.12%。沪股通减持金额前五个股分别为陕西煤业、安琪酵母、招商银行、中国神华、福耀玻璃。中国医药近5个交易日上涨5.41%,沪股通累计减持682.97万股;近20个交易日上涨3.37%,沪股通累计减持967.26万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022109302683504981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023022109302683504981&s=b","is_publish_highlight":false},{"id":"2312376737","title":"医药商业板块开盘下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2312376737","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2312376737?lang=zh_CN&edition=full","pubTime":"2023-02-20 09:31","pubTimestamp":1676856693,"startTime":"0","endTime":"0","summary":"快讯摘要医药商业板块开盘下挫:医药商业板块开盘下挫,药易购跌超5%,健之佳、第一医药跌超4%,漱玉平民、中国医药等跟跌。快讯正文医药商业板块开盘下挫:医药商业板块开盘下挫,药易购跌超5%,健之佳、第一医药跌超4%,漱玉平民、中国医药等跟跌。下载和讯APP查看快讯,体验更佳>>","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230220093640825f0014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230220093640825f0014&s=b","is_publish_highlight":false},{"id":"2312400743","title":"医药股午后持续走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2312400743","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2312400743?lang=zh_CN&edition=full","pubTime":"2023-02-17 13:10","pubTimestamp":1676610616,"startTime":"0","endTime":"0","summary":"快讯摘要医药股午后持续走强:医药股午后持续走强,特一药业、新华制药涨停,以岭药业涨超6%,神奇制药、中国医药、众生药业等跟涨。快讯正文医药股午后持续走强:医药股午后持续走强,特一药业、新华制药涨停,以岭药业涨超6%,神奇制药、中国医药、众生药业等跟涨。下载和讯APP查看快讯,体验更佳>>","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230217131853840fd007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230217131853840fd007&s=b","is_publish_highlight":false},{"id":"2312406233","title":"公司有自己的中药种植基地吗? 中国医药回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2312406233","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2312406233?lang=zh_CN&edition=full","pubTime":"2023-02-17 10:28","pubTimestamp":1676600886,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问: 1、公司有自己的中药种植基地吗? 2、规模多大? 3、注意是哪些品种?中国医药(600056.SH)2月17日在投资者互动平台表示,公司在吉林、宁夏、四川、甘肃、广西等地通过自建和合作共建的模式,建立了人参、甘草、麻黄、大黄、黄芪、甜茶叶、小茴香等多种药材种植基地。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230217102824825df82f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230217102824825df82f&s=b","is_publish_highlight":false},{"id":"2311468688","title":"中国医药2月15日获融资净买入2066万元 环比增加341.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2311468688","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311468688?lang=zh_CN&edition=full","pubTime":"2023-02-16 10:00","pubTimestamp":1676512828,"startTime":"0","endTime":"0","summary":"2月15日,中国医药获融资净买入2066万元,环比上一交易日增加341.38%。其中,融资买入5179万元,融资偿还3113万元。融券方面,融券卖出13.35万股,当前融券余量为85.33万股。A股市场共有2356股获融资净买入,中国医药净买入额排名第84。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216100116846d8521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216100116846d8521&s=b","is_publish_highlight":false},{"id":"2311452488","title":"中国医药2月15日遭北向资金减持332.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2311452488","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311452488?lang=zh_CN&edition=full","pubTime":"2023-02-16 09:30","pubTimestamp":1676511006,"startTime":"0","endTime":"0","summary":"2月15日,北向资金减持中国医药332.52万股。截止当日收盘,沪股通共持有中国医药2163.14万股,占流通股1.44%。沪股通减持金额前五个股分别为中国平安、隆基绿能、东方电气、紫金矿业、璞泰来。中国医药近5个交易日上涨1.00%,沪股通累计增持230.77万股;近20个交易日下跌1.43%,沪股通累计减持974.23万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216093026806153ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230216093026806153ea&s=b","is_publish_highlight":false},{"id":"2311180545","title":"中国医药2月13日获北向资金加仓277.23万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2311180545","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2311180545?lang=zh_CN&edition=full","pubTime":"2023-02-14 09:30","pubTimestamp":1676338206,"startTime":"0","endTime":"0","summary":"2月13日, 北向资金增持中国医药277.23万股。截止当日收盘,沪股通共持有中国医药2361.10万股,占流通股1.57%。沪股通增持金额前五个股分别为三一重工、天合光能、招商银行、海天味业、恒生电子。中国医药近5个交易日上涨0.40%,沪股通累计增持503.62万股;近20个交易日下跌6.48%,沪股通累计减持500.96万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214093018834ed8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230214093018834ed8a5&s=b","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"1997-05-15","address":"北京市东城区光明中街18号","stockEarnings":[{"period":"1week","weight":-0.0317},{"period":"1month","weight":-0.1112},{"period":"3month","weight":-0.2584},{"period":"6month","weight":0.142},{"period":"1year","weight":-0.4693},{"period":"ytd","weight":-0.202}],"companyName":"中国医药健康产业股份有限公司","boardCode":"AI0051","perCapita":"6877股","boardName":"批发业","registeredCapital":"149587万元","compareEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0541},{"period":"6month","weight":0.0713},{"period":"1year","weight":0.0113},{"period":"ytd","weight":0.0488}],"survey":" 中国医药健康产业股份有限公司建立了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的贸、工、技、服一体化产业格局,全面推动工商贸三大业务板块业务整合,积极发挥协同优势。主要产品有原料药、制剂药、中成药、医药商业、国际贸易。从最新公布的权威行业排名显示,公司位列2020年度中国医药工业百强榜化药企业排名第35位;中国医药-重庆医药联合体位列2020年医药流通百强第5位。","serverTime":1680178147831,"listedPrice":7.02,"stockholders":"217433人(较上一季度减少6.49%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.12.1","shortVersion":"4.12.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国医药,600056,中国医药股票,中国医药股票老虎,中国医药股票老虎国际,中国医药行情,中国医药股票行情,中国医药股价,中国医药股市,中国医药股票价格,中国医药股票交易,中国医药股票购买,中国医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}